
AMA, Vaccine Integrity Project launch independent vaccine review; tirzepatide tied to lower diabetic eye disease risk; ACLM updates guidance of treatment, prevention of chronic disease – Morning Medical Update
Key Takeaways
- AMA and the Vaccine Integrity Project will apply a structured, evidence-based framework to reassess influenza, COVID-19, and RSV vaccine safety and effectiveness for 2026–27 clinical guidance.
- The review process is designed to be transparent and durable, with medical societies shaping policy-relevant questions and incorporating updated datasets as evidence evolves.
The top news stories in medicine today.
The American Medical Association (AMA) and the University of Minnesota’s Vaccine Integrity Project are launching a structured,
Patients with diabetes taking tirzepatide (Mounjaro, Zepbound) were significantly less likely to develop or experience worsening diabetic retinopathy compared with similar patients pursuing lifestyle changes alone, according to a study of about 174,000 patients published in
The
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.






